Launch of the Life Science Directory for Medicen Paris
Zurich / Paris, Oct 2020 – Venture Valuation owned Biotechgate announces the partnership with Medicen Paris Region to create a directory of Life Sciences companies. The online directory makes it easier to find partners in one of the key clusters in Europe.
Venture Valuation/Biotechgate is proud to announce the launch of the Life Science Directory for Medicen Paris created as a result of the partnership between Venture Valuation/Biotechgate and the Medicen biocluster. The directory is accessible for free on the Medicen Paris Region website and features profiles of life science companies located in the region. Advanced search options and an interactive map help to access relevant information very quickly.
Medicen Paris Region is the largest life science industry organization in France. The hub represents nearly 500 Medtech, Biotech, e-Health companies, but also Big Pharma and Academics and aim to position the Paris Region as a European leader in the healthcare industry. The directory gathers Medicen’s members through 6 areas: Biotech Therapeutics and Diagnostics, Biotech/ R&D Services, Pharma, Medical Technology, Digital Health, Supplier, Investors, and Others.
“Entering a partnership with Medicen Paris Region was an important step for us because it is one of the largest life science clusters in Europe. Online business development has received a boost in the recent month, thus tools like the online directory will help companies to continue their deal making activities. Medicen is also an organization that is exceptionally active in promoting its members, so it has been great working with Medicen Paris Region in creating the directory.” Dr. Patrik Frei, CEO and Founder of Venture Valuation/Biotechgate
“Medicen’s cross-functional expertise allows us to support companies in biotech, medtech as well as e-health fields. The directory built with Venture Valuation/Biotechgate represents an additional opportunity for our network to connect. This partnership strengthens Medicen’s commitment to health innovation ecosystem networking, advise in setting up projects and boost the visibility of its members to offer them the keys to success, in France and internationally.” Jessica Leygues, CEO of Medicen Paris Region
The directory is published at:
Venture Valuation AG – www.venturevaluation.com
Venture Valuation specializes in independent, third-party assessment and valuation of biotechnology, pharma and med-tech companies. Services are provided in the form of independent Valuation Reports to entrepreneurs (seed to pre-IPO) and investors. With offices in Switzerland, Ireland, UK, Canada, USA and Asia, Venture Valuation has an experienced team of scientists and business professionals with expertise in finance, biotechnology, pharmaceutical and regulatory.
Biotechgate – www.biotechgate.com
Biotechgate is a business development database that contains over 55,000 high-quality profiles of life science companies which include company descriptions, contact information, product pipeline information, financing rounds, management details, and licencing deals. In 2019 a clinical trial database containing over 500,000 records was added to Biotechgate. The new database is integrated with registries around the world.
Medicen Paris Region – medicen.org
The Medicen cluster creates a network of excellence in innovation within the Paris region and beyond. By bringing together private and public players around innovation challenges and with the ambition of developing the therapeutic solutions of tomorrow, Medicen is a trusted third party, supporting the development and completion of projects.
In order to promote the growth of the sector, the introduction on the market of innovative healthcare products and the creation of jobs, the cluster acts on three levels:
- Facilitate and encourage the emergence of innovation projects and support their development.
- Put the right partners in touch with each other to give projects the best possible chance of success.
- Direct project leaders towards the best public funding mechanisms and help them to obtain funds.
Would you like to be notified about new reports and other valuable content published by Biotechgate?